via Reuters "Investors were most encouraged by the performance of the lower 4 mg dose of retatrutide, which produced roughly 19% weight loss, comparable to the highest dose of current blockbuster therapy Zepbound." #pharmacy #GLP #healthcare To view or add a comment, sign in The most interesting part of Pfizers latest obesity data isnt the 12.3% placebo-adjusted weight loss, its the fact that it was achieved while transitioning patients to once-monthly dosing
Most report: Smaller meal portions Less snacking Reduced cravings Better control over emotional eating 2
Following the acute phase of COVID-19, the presence of more than one symptom is quite prevalent, occurring in 74% [11, 12] to 87.4% of all infected patients [12]
Calculations were performed using the Seahorse Wave Pro Software (Agilent)
Patients across Phoenix choose us for a reason: Better care
A medical professional will make sure the plan is right for you